Bolt Biotherapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-47.3M | $-50.6M | $3.3M | $1.4M |
| FY2021 | $-57.1M | $-59.4M | $2.3M | $8.5M |
| FY2022 | $-76.5M | $-78.5M | $2.0M | $9.6M |
| FY2023 | $-69.5M | $-69.7M | $206.0K | $9.2M |
| FY2024 | $-61.3M | $-61.3M | $41.0K | $7.4M |
| FY2025 | $-39.9M | $-39.9M | $72.0K | $2.8M |